Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Global Studies to Test Efficacy of HIV Drugs

By HospiMedica staff writers
Posted on 17 Apr 2001
Two large global studies testing the effectiveness of HIV drugs are being undertaken by the Academic Medical Center—International Antiviral Therapy Evaluation Center in Amsterdam (The Netherlands).

The first study, on compact highly active antiretroviral medication (CHARM), will evaluate the effect of combivir and abacavir in HIV-1 infected subjects without previous anti-HIV treatment. More...
This study will also explore the effects of short-term immunosuppressive therapy. The study will involve 225 patients in South Africa, Western and Eastern Europe, and Canada over a 72-week period.

The second study is an open-label comparative study to evaluate the short-term antiviral efficacy of nevirapine and efavirenz or both drugs together in combination with stavudine and lamivudine. This study will involve 1,200 patients in Europe, the United States, South America, Australia, and Thailand over a 48-week period.

The testing will be conducted by the clinical trials testing division of Laboratory Corp. of America Holdings (LabCorp, Mechelen, Belgium), using the Roche Amplicor HIV polymerase chain reaction (PCR) assay and ultra-sensitive assay. LabCorp's clinical trials division is a central laboratory supporting global pharmaceutical, biotechnology, and medical device clinical trials.




Related Links:
LabCorp

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.